Leaps by Bayer — 2020 Investments
2 investments dated 2020 · listed companies and verified rows first · show all
Azitra is a clinical-stage biopharmaceutical company developing genetically engineered bacteria and proteins for treating skin diseases through precision dermatology.
AI & Machine LearningBiotechHealthtechFarmington, US
Francisco D. Salva(President and Chief Executive Officer)inAzim Munivar(Executive Officer, Director, Promoter)
BoardStella Robertson(Director)inTravis Whitfill(Executive Officer, Director, Promoter)in
Co-investorsBios PartnersConnecticut InnovationsKdT Ventures
Triumvira is a clinical-stage immuno-oncology company developing autologous and allogeneic T cell therapeutics for cancer treatment.
BiotechHealthtechMedical DevicesAustin, US
TERESA MCROBERTS(Executive Officer)inPAUL LAMMERS, MD, MSc(Executive Officer, Director)inJON IRVIN(Executive Officer)in
BoardDANIEL JANSE(Director)JURGEN ECKHARDT(Director)ELIZABETH WILLIAMS(Director)
Co-investorsB Capital GroupB4 CapitalCheckmate Capital Group LLCNorthpond VenturesOceanpine Capital
.jpeg){kind=logo}
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.